- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04970615
Educating Brain Tumor Patients Using Patient-specific Actual-size Three-dimensional Printed Models (IMAGE-3D)
Educating Brain Tumor Patients Using Patient-specific Actual-size Three-dimensional Printed Models: a Case-control Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Objectives The main goal of this project is to evaluate the role of 3D models on different aspects of patient education (patient experiences and information recall) in patients with brain tumors by comparing these to the use of standard 2D Magnetic Resonance (MR) images. A secondary goal is to gain more insight into the experiences of the close ones of the patients.
Study population We will conduct a case control, multi-center study in the Radboud University Medical Center (Radboudumc) Maastricht University Medical Center (MUMC). Patients will be enrolled in the control group until inclusion for the control group is completed (n=30), after which patients will be enrolled in the intervention group (n=30). The control group will consist of patients who will be informed using MR images during pre-operative consultations. The intervention group will be informed using personalized, life-size 3D models during pre-operative consultations. Inclusion time is estimated to be around 2 years.
Sample size Previous studies on this topic are scarce. In our experimental study on this subject [Sezer et al. 2020], we found an improvement of 5% (minimum expected difference, D) in information recall when using 3D models compared to 2D models. The standard deviation (SD) for information recall based on this study is approximately 5. With a significance criterion of 0.05 and power of 0.90 we calculated a total sample size of 42. For this study, however, we expect to find a smaller effect size due to the confounding factors (cognitive functioning, emotional status) which were eliminated in our experimental study in healthy individuals. Therefore we want to enroll 30 patients in each group (total sample size 60).
Study procedures Eligible patients will be asked to participate by their clinician or nurse practitioner who will they will receive an information letter and informed consent (attachment E1.1). The researcher will contact the patient to officially collect the informed consent form. Afterwards, the researcher will send out the link to the questionnaires collecting the baseline characteristics, emotional status questionnaire (HADS) and the ACS. The patient will be instructed to finish these questionnaires before the pre-operative consultation. Pre-operative preparation will be the same for the control and intervention group. The only difference will be the visual tool used in the pre-operative consult. Afterwards, the patient will be called by the researcher on the same or following day. A link will be sent out with the questionnaires on experiences, information recall and chosen treatment for the brain tumor. All questionnaires will be collected through Castor EDC © 2019.
The clinician will also be asked to fill out the questionnaire on information recall.
After the pre-operative consultation, we will ask the participant whether we can contact their close one. After reading the information letter and signing the informed consent the close one will receive the online questionnaires testing information recall and experiences. Both questionnaires will be collected through Castor EDC © 2019.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Sümeyye Sezer, MD
- Phone Number: +31640486170
- Email: Sumeyye.Sezer@radboudumc.nl
Study Contact Backup
- Name: Mark ter Laan, MD, PhD
- Phone Number: +31621175664
- Email: Mark.terLaan@radboudumc.nl
Study Locations
-
-
Gelderland
-
Nijmegen, Gelderland, Netherlands
- Recruiting
- Radboud University Medical Center
-
Contact:
- Mark ter Laan, MD, PhD
- Phone Number: +31621175664
- Email: Mark.terLaan@radboudumc.nl
-
Contact:
- Sümeyye Sezer, MD
- Phone Number: +31640486170
- Email: Sumeyye.Sezer@radoudumc.nl
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patient with a brain tumor
- functional imaging (MRI, functional MRI (fMRI) and Diffusion Tensor Imaging (DTI)) requested for pre-operative planning
Exclusion Criteria:
- Inadequate understanding of the Dutch language
- Inability to independently use a computer
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Two-dimensional images
Patients who receive pre-operativeinformation while the two-dimensional MR images are being shown to them by the neurosurgeon.
|
|
|
Three-dimensional printed model
Patients who receive pre-operative information while the three-dimensional printed models are being shown to them by the neurosurgeon.
|
Three-dimensional printers are able to print physical objects in real size and colours.
As a respresentative of the real tumor, a personalized three-dimensional model enables visualization of the patient-specific tumor and eloquent areas.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Immediate information recall
Time Frame: 24 hours
|
24 hours
|
|
Delayed information recall
Time Frame: One week
|
One week
|
|
Patient experiences
Time Frame: 24 hours
|
24 hours
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Inclusion rate of patients meeting the inclusion criteria
Time Frame: 30 months
|
30 months
|
|
Number of patients with completed follow-up at 1 week
Time Frame: 1 week
|
1 week
|
|
Time between pre-operative consultation and immediate information recall questionnaire
Time Frame: 24 hours
|
24 hours
|
|
Time between pre-operative consultation and delayed information recall questionnaire
Time Frame: 1 week
|
1 week
|
|
Educational level
Time Frame: 30 months
|
30 months
|
|
Cognitive functioning
Time Frame: 30 months
|
30 months
|
Collaborators and Investigators
Sponsor
Publications and helpful links
General Publications
- Watson PW, McKinstry B. A systematic review of interventions to improve recall of medical advice in healthcare consultations. J R Soc Med. 2009 Jun;102(6):235-43. doi: 10.1258/jrsm.2009.090013.
- Kessels RP. Patients' memory for medical information. J R Soc Med. 2003 May;96(5):219-22. doi: 10.1177/014107680309600504. No abstract available.
- Rutten LJ, Arora NK, Bakos AD, Aziz N, Rowland J. Information needs and sources of information among cancer patients: a systematic review of research (1980-2003). Patient Educ Couns. 2005 Jun;57(3):250-61. doi: 10.1016/j.pec.2004.06.006.
- Phelps EE, Wellings R, Griffiths F, Hutchinson C, Kunar M. Do medical images aid understanding and recall of medical information? An experimental study comparing the experience of viewing no image, a 2D medical image and a 3D medical image alongside a diagnosis. Patient Educ Couns. 2017 Jun;100(6):1120-1127. doi: 10.1016/j.pec.2016.12.034. Epub 2016 Dec 30.
- Zhuang YD, Zhou MC, Liu SC, Wu JF, Wang R, Chen CM. Effectiveness of personalized 3D printed models for patient education in degenerative lumbar disease. Patient Educ Couns. 2019 Oct;102(10):1875-1881. doi: 10.1016/j.pec.2019.05.006. Epub 2019 May 8.
- van de Belt TH, Nijmeijer H, Grim D, Engelen LJLPG, Vreeken R, van Gelder MMHJ, Ter Laan M. Patient-Specific Actual-Size Three-Dimensional Printed Models for Patient Education in Glioma Treatment: First Experiences. World Neurosurg. 2018 Sep;117:e99-e105. doi: 10.1016/j.wneu.2018.05.190. Epub 2018 Jun 2.
- Sezer S, Piai V, Kessels RPC, Ter Laan M. Information Recall in Pre-Operative Consultation for Glioma Surgery Using Actual Size Three-Dimensional Models. J Clin Med. 2020 Nov 13;9(11):3660. doi: 10.3390/jcm9113660.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Neoplasms by Histologic Type
- Neoplasms
- Neoplasms by Site
- Neoplasms, Glandular and Epithelial
- Glioma
- Neoplasms, Neuroepithelial
- Neuroectodermal Tumors
- Neoplasms, Germ Cell and Embryonal
- Neoplasms, Nerve Tissue
- Central Nervous System Neoplasms
- Nervous System Neoplasms
- Glioblastoma
- Brain Neoplasms
- Astrocytoma
- Oligodendroglioma
Other Study ID Numbers
- 2021-7292
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Glioma
-
University of California, San FranciscoPacific Pediatric Neuro-Oncology ConsortiumRecruitingPediatric Cancer | Low-grade Glioma | Low Grade Glioma of Brain | Recurrent Low Grade GliomaUnited States
-
Ohio State University Comprehensive Cancer CenterRecruitingWHO Grade 3 Glioma | Recurrent Malignant Glioma | WHO Grade 2 Glioma | Recurrent WHO Grade 3 Glioma | Recurrent WHO Grade 4 Glioma | WHO Grade 4 GliomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI); Food and Drug Administration (FDA)Active, not recruitingRecurrent Glioblastoma | Recurrent Malignant Glioma | Refractory Malignant Glioma | Recurrent WHO Grade III Glioma | Recurrent WHO Grade II Glioma | Refractory Glioblastoma | Refractory WHO Grade II Glioma | Refractory WHO Grade III GliomaUnited States
-
Children's Hospital of PhiladelphiaBlue Earth Diagnostics; Dragon Master FoundationRecruitingGlioma | Low-grade Glioma | Glioma, Malignant | Low Grade Glioma of Brain | Glioma IntracranialUnited States
-
Children's Hospital of PhiladelphiaBlue Earth Diagnostics; Dragon Master FoundationRecruitingGlioma | High Grade Glioma | Glioma, Malignant | Diffuse Glioma | Glioma IntracranialUnited States
-
ChimerixOncoceutics, Inc.TerminatedGlioblastoma | Diffuse Midline Glioma | H3 K27M Glioma | Thalamic Glioma | Infratentorial Glioma | Basal Ganglia GliomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingGlioblastoma | Malignant Glioma | WHO Grade III Glioma | Recurrent Glioma | Refractory GliomaUnited States
-
University of California, San FranciscoBeiGene USA, Inc.Active, not recruitingGlioblastoma | Malignant Glioma | Recurrent Glioblastoma | Recurrent WHO Grade III Glioma | WHO Grade III Glioma | IDH2 Gene Mutation | IDH1 Gene Mutation | Low Grade Glioma | Recurrent WHO Grade II Glioma | WHO Grade II GliomaUnited States
-
Sabine Mueller, MD, PhDNot yet recruitingGlioblastoma | Diffuse Midline Glioma, H3 K27M-Mutant | High-grade Glioma | High-Grade Glioma (WHO III-IV) | Diffuse Hemispheric Glioma, H3G34 MutantUnited States
-
Xiangya Hospital of Central South UniversityRecruitingGliomas | Glioma, Diffuse Midline, H3K27M-mutant | Glioma of Brainstem | Glioma Glioblastoma Multiforme | Glioma : Oligodendroglioma or Astrocytoma | Gliomas Harboring IDH1 and/or IDH2 MutationsChina
Clinical Trials on Three-dimensional printed model
-
Brigham and Women's HospitalNot yet recruitingHemodialysis Access FailureUnited States
-
Cairo UniversityUnknownOrthodontic Appliance Complication
-
Chinese University of Hong KongCompleted
-
Necmettin Erbakan UniversityCompletedThirst in Intensive Care Unit (ICU) PracticeTurkey (Türkiye)
-
Assiut UniversityCompleted
-
University Health Network, TorontoTerminatedMullerian Duct AnomalyCanada
-
Zuyderland Medisch CentrumRadboud University Medical CenterCompletedChest Wall DisorderNetherlands
-
Beijing Luhe HospitalUnknownPrinting, Three-Dimensional, Simulation TrainingChina
-
Felix CorrNot yet recruitingSpinal Diseases | Randomized Controlled Trial | Simulation Training | Endoscopy Simulation | Three-Dimensional | Lumbar Vertebrae
-
University of CincinnatiEnrolling by invitationMandible Fracture | Maxillofacial TraumaUnited States